David M. Clark

Representative Public Target Transactions

• Akoya Biosciences (AKYA) in its acquisition by Quanterix (QTRX)
• MedImpact in its acquisition of the pharmacy benefit management business of Rite Aid (RAD)*
• Xperi (XPER) in multiple cross-border divestitures
• SeaSpine (SPNE) in its merger of equals with Orthofix Medical (OFIX)
• GenMark Diagnostics (GNMK) in its acquisition by Roche
• Woven by Toyota (TM) in its acquisition of the autonomous vehicle division of Lyft (LYFT)
• Medtronic (MDT) in its acquisition of Medicrea (ALMED)
• Maxwell Technologies (MXWL) in its acquisition by Tesla, Inc. (TSLA)
• The Active Network (ACTV) in its acquisition by Vista Equity Partners
• PF Chang's China Bistro (PFCB) in its acquisition by Centerbridge Partners

*Named M&A Advisor's Healthcare/Life Sciences Deal of the Year

Representative Private Target Transactions

• NIKE, Inc. (NKE) in several domestic and cross-border acquisitions
• Woven by Toyota (TM), in several cross-border acquisitions
• DexCom (DXCM) in multiple cross-border acquisitions
• Yamaha in multiple cross-border acquisitions.
• LEGO in multiple cross-border acquisitions
• Telesis Bio (DNAY) in its acquisition and divestiture of Eton Bio
• Agena Bioscience in its acquisition by Mesa Labs (MLAB)
• Specific Diagnostics in its acquisition by bioMérieux (BMX)
• Aumni in its acquisition by JP Morgan (JPM)
• Rallyware in its acquisition of Myagi
• Qualcomm in multiple domestic and cross-border acquisitions